• About
  • Subscribe
  • Advertise
  • Contact
Sunday, May 18, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Company secures funding to develop eyewear that adapts to wearer’s eyes

by Staff Writer
May 5, 2025
in Devices, Eye research institutions, International, News, Ophthalmic insights, Optical, Products, Research, Smart glasses, Technology
Reading Time: 3 mins read
A A
A Finnish company is developing eyewear that adapts to a person's eyes. 
Image: Siripong/stock.adobe.com

A Finnish company is developing eyewear that adapts to a person's eyes. Image: Siripong/stock.adobe.com

Share on FacebookShare on Twitter

IXI, a Finnish eyewear hardware company, has raised US$36.5 million (AU$56.5 million) in funding to develop what it says is the world’s first autofocus lenses for eyewear that adapt to the wearer’s eyes.

An article in siliconAngle said the Series A round was led by Plural, with participation from byFounders, Heartcore, Eurazeo, FOV Ventures and Tiny Supercomputer, alongside the company’s existing investors, including Amazon Alexa Fund, First Fellow and half a dozen others.

Founded in 2021, IXI’s founders, chief executive Mr Niko Eiden and chief algorithm officer Mr Ville Miettinen previously co-founded the premium mixed reality hardware startup Varjo Technologies Oy.

There they gained experience with advanced optics for augmented reality and mixed reality devices that require precision lenses for eye-tracking solutions, which inspired them to create dynamic lenses for everyday eyewear that could solve challenges for vision correction.

“Eyewear is the world’s oldest wearable, rooted in centuries of brilliance across science, design and craftsmanship,” said Eiden. “That being said, it’s incredible that we haven’t seen more technology leaps, leaving millions of people forced to compromise on how they see the world.”

The article said that, as individuals aged, eyesight tended to worsen, often leading to age-related farsightedness, otherwise known as presbyopia.

Some people have reading glasses for viewing close-up objects or purchase bifocal or multifocal glasses. Multifocal glasses require people to look through a specific portion of the lens to see close or far objects with clarity.

Although to many wearers the action becomes second nature, these glasses do come with some limitations, such as reducing their field of view and distorting objects in the periphery.

“The time for change is now,” Eiden said. “We’re creating a whole new era in vision tech — and we can’t wait to show the world what’s coming.”

IXI said it wanted to design its glasses with an eye for fashion. By partnering with luxury eyewear designers, its smart eyewear frames will look similar to high-end glasses rather than an assistive device.

Unlike traditional eye-tracking systems found in mixed reality headsets, IXI’s approach uses a proprietary low-power infrared system built directly into the lenses. Instead of tracking eye movement, it measures eye convergence, the subtle angle your eyes turn inward when focusing on something up close. That data is sent to a tiny microcontroller embedded in the nose bridge, which dynamically adjusts the lens focus in real time.

According to the company it uses less than 1% of the energy required by camera-based trackers, enabling all-day battery life for the tiny cells embedded in the frames.

Although the company said it initially intends to focus on age-related vision correction, the adaptive lens technology could have implications for other eyesight issues. The ultra-low-power capabilities and thin lens design would also make it useful for integration within AR/VR headsets.

More reading 

COVID-19 virus shown to breach retinal barrier and damage the eye

Visual test could predict dementia onset a decade before diagnosis

Advancements in 3D printing could revolutionise IOL production

 

Related Posts

Dr Lourens van Zyl recently switched to Blink eye drops in his clinic. Images: B+L.

Bausch + Lomb’s blinking success

by Staff Writer
May 17, 2025

Every second counts in Dr Lourens van Zyl’s busy Perth clinic, motivating him to switch to a new lubricating eye...

The cost of intravitreal eye injections to manage macular degeneration can discourage many older Australians from continuing treatment. Image: Rose Makin/stock.adobe.com.

Special Report: Intravitreal injections and bulk billing – good for business

by Rob Mitchell
May 16, 2025

Frequent intravitreal injections are vital to help many older Australians keep their eyesight, but the costs can be prohibitive. Insight...

A scene from the movie My Eyes, featuring optometrist Tsu Shan Chambers (right). Image: FanForce Films.

My Eyes film starring Australian optometrist set to open in theatres

by Staff Writer
May 16, 2025

A film highlighting the remarkable journey of a Australian mother determined to save her daughter’s eyesight, and starring a practising...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited